Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Henry Schein (HSIC)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Elanco Animal Health (ELAN – Research Report) and Henry Schein (HSIC – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Elanco Animal Health (ELAN)
Leerink Partners analyst Daniel Clark reiterated a Buy rating on Elanco Animal Health today and set a price target of $30.00. The company’s shares closed last Tuesday at $25.73.
Clark has an average return of
According to TipRanks.com, Clark is ranked #3225 out of 12136 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Elanco Animal Health with a $27.60 average price target, representing a 14.7% upside. In a report issued on February 16, Bank of America Securities also maintained a Buy rating on the stock with a $28.00 price target.
See today’s best-performing stocks on TipRanks >>
Henry Schein (HSIC)
In a report released today, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein, with a price target of $87.00. The company’s shares closed last Tuesday at $83.80.
According to TipRanks.com, Cherny is a 4-star analyst with an average return of
Currently, the analyst consensus on Henry Schein is a Moderate Buy with an average price target of $88.50, which is a 5.4% upside from current levels. In a report released yesterday, William Blair also maintained a Hold rating on the stock.
